Anterior chamber inoculation of splenocytes without Fas/Fas‐ligand interaction primes for a delayed‐type hypersensitivity response rather than inducing anterior chamber‐associated immune deviation

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

1992 • 2,932 citations

Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family

1993 • 2,546 citations

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1995 • 2,028 citations

Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand

1994 • 1,549 citations

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas

1995 • 1,346 citations

A role for CD95 ligand in preventing graft rejection

1995 • 1,184 citations

Immunologically Privileged Sites

1978 • 815 citations

Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.

1993 • 801 citations

Fas ligand in human serum

1996 • 682 citations

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

1995 • 656 citations

Purification and characterization of the Fas-ligand that induces apoptosis.

1994 • 521 citations

Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice

1996 • 456 citations

CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological Tolerance

1996 • 394 citations

Differential expression of bcl-2 and susceptibility to anti-Fas- mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils

1994 • 320 citations

Unraveling Immune Privilege

1995 • 302 citations

Immune regulation and the eye: a dangerous compromise

1987 • 217 citations

Fluids from immune privileged sites endow macrophages with the capacity to induce antigen‐specific immune deviation via a mechanism involving transforming growth factor‐β

1992 • 206 citations

Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.

1991 • 179 citations

Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID.

1991 • 144 citations

Organ-Resident, Nonlymphoid Cells Suppress Proliferation of Autoimmune T-Helper Lymphocytes

1987 • 118 citations

Anterior chamber-associated immune deviation promotes corneal allograft survival.

1996 • 115 citations

Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye

1992 • 77 citations

Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production.

1994 • 57 citations

Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye.

1992 • 55 citations

Intracameral injection of allogeneic lymphocytes enhances corneal graft survival.

1990 • 46 citations

A Soluble Product of Human Corneal Fibroblasts Inhibits Lymphocyte Activation. Enhancement by Interferon-gamma

1993 • 41 citations

Induction of anterior chamber-associated immune deviation (ACAID) by allogeneic intraocular tumors does not require splenic metastases.

1982 • 32 citations

Insufficient expression of Fas antigen on helper T cells in Behcet's disease.

1996 • 20 citations

Incomplete activation of lymphokine-producing T cells by alloantigenic intraocular tumours in anterior chamber-associated immune deviation.

1993 • 8 citations

Suppression of graft rejection in rat keratoepithelioplasty by anterior chamber inoculation of donor lymphocytes.

1994 • 5 citations